|
SC5DL expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66560012846173E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3796999986937E-08 |
| Normal-vs-Stage2 |
2.902200E-02 |
| Normal-vs-Stage3 |
2.29510000004929E-06 |
| Normal-vs-Stage4 |
8.613800E-04 |
| Stage1-vs-Stage2 |
1.988810E-01 |
| Stage1-vs-Stage3 |
6.598200E-01 |
| Stage1-vs-Stage4 |
2.818000E-01 |
| Stage2-vs-Stage3 |
1.624200E-01 |
| Stage2-vs-Stage4 |
8.534400E-02 |
| Stage3-vs-Stage4 |
4.285000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8718000038831E-08 |
| Normal-vs-AfricanAmerican |
5.963800E-03 |
| Normal-vs-Asian |
1.257930E-03 |
| Caucasian-vs-AfricanAmerican |
4.274600E-01 |
| Caucasian-vs-Asian |
8.379000E-01 |
| AfricanAmerican-vs-Asian |
5.989800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.400360E-04 |
| Normal-vs-Female |
2.49509968242023E-10 |
| Male-vs-Female |
2.587000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.83839999574099E-08 |
| Normal-vs-Age(41-60Yrs) |
4.50470000190606E-08 |
| Normal-vs-Age(61-80Yrs) |
6.007000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.871350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.929400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.675800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.133200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.460800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.841600E-02 |
| Classical-VS-Follicular |
4.766400E-02 |
| Classical-VS-Other |
9.448600E-01 |
| Classical-VS-Normal |
7.30129956494352E-10 |
| Tall-VS-Follicular |
2.020200E-03 |
| Tall-VS-Other |
2.796600E-01 |
| Tall-VS-Normal |
1.0538000000393E-06 |
| Follicular-VS-Other |
5.499400E-01 |
| Follicular-VS-Normal |
1.844970E-03 |
| Other-VS-Normal |
8.037800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6589999999892E-06 |
| Normal-vs-N1 |
3.239000E-03 |
| N0-vs-N1 |
6.990000E-01 |
|
|
